Mallinckrodt Pharmaceuticals
Recent News About Mallinckrodt Pharmaceuticals
-
Mallinckrodt president says company will weather $1.6 billion opioid litigation settlement
ST. LOUIS – The president of Mallinckrodt Pharmaceuticals, the country’s biggest manufacturer of generic opioids, said the company would weather a $1.6 billion agreement to settle thousands of lawsuits and go on to a brighter future. -
Second company added to suit filed over dumping of radioactive waste in St. Louis-area landfill
A company tasked with cleaning up a St. Louis-area landfill contaminated by radioactive waste has filed an amended compliant accusing a second firm of responsibility for some of the remediation work.